Skip to main content
. 2021 Jul 13;10(2):308–320. doi: 10.14218/JCTH.2021.00096

Fig. 8. Correlations between the risk score and immune-related genes, immune subtypes, tumor stemness, and drug susceptibility in HCC.

Fig. 8

(A–B) Correlation between the risk score and the expression of PD-1, CTLA-4, and TIM3 in the training and validation groups. (C–D) Distribution of the risk score and immune subtypes in HCC. *p<0.05, **p<0.01, ***p<0.001. CTLA-4, cytotoxic T lymphocyte-associated antigen-4; HCC, hepatocellular carcinoma; lncRNAs, long noncoding RNAs; m6A, N6-methyladenosine; PD-1, programmed cell death 1; TCGA, The Cancer Genome Atlas; TIM3, T-cell immunoglobulin and mucin domain 3.